AR226154A1 - Procedimiento para preparar derivados de 3-alquil(c1-c4)carbamoil-sulfonamido-4-amino-piridina y sus sales farmaceuticamente aceptables - Google Patents

Procedimiento para preparar derivados de 3-alquil(c1-c4)carbamoil-sulfonamido-4-amino-piridina y sus sales farmaceuticamente aceptables

Info

Publication number
AR226154A1
AR226154A1 AR275290A AR27529079A AR226154A1 AR 226154 A1 AR226154 A1 AR 226154A1 AR 275290 A AR275290 A AR 275290A AR 27529079 A AR27529079 A AR 27529079A AR 226154 A1 AR226154 A1 AR 226154A1
Authority
AR
Argentina
Prior art keywords
carbamoil
piridine
sulfonamido
amino
alkyl
Prior art date
Application number
AR275290A
Other languages
English (en)
Spanish (es)
Original Assignee
Christiaens Sa A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Christiaens Sa A filed Critical Christiaens Sa A
Application granted granted Critical
Publication of AR226154A1 publication Critical patent/AR226154A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72Nitrogen atoms
    • C07D213/75Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10Antioedematous agents; Diuretics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72Nitrogen atoms
    • C07D213/74Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
AR275290A 1978-01-31 1979-01-25 Procedimiento para preparar derivados de 3-alquil(c1-c4)carbamoil-sulfonamido-4-amino-piridina y sus sales farmaceuticamente aceptables AR226154A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB3918/78A GB1593609A (en) 1978-01-31 1978-01-31 Pyridine sulfonamides

Publications (1)

Publication Number Publication Date
AR226154A1 true AR226154A1 (es) 1982-06-15

Family

ID=9767352

Family Applications (2)

Application Number Title Priority Date Filing Date
AR275290A AR226154A1 (es) 1978-01-31 1979-01-25 Procedimiento para preparar derivados de 3-alquil(c1-c4)carbamoil-sulfonamido-4-amino-piridina y sus sales farmaceuticamente aceptables
AR281219A AR225922A1 (es) 1978-01-31 1980-05-28 Procedimiento para preparar nuevos derivados de 3-carbamoil-sulfonamido-4-amino-piridina y sus sales

Family Applications After (1)

Application Number Title Priority Date Filing Date
AR281219A AR225922A1 (es) 1978-01-31 1980-05-28 Procedimiento para preparar nuevos derivados de 3-carbamoil-sulfonamido-4-amino-piridina y sus sales

Country Status (20)

Country Link
US (1) US4244950A (xx)
EP (1) EP0003383B1 (xx)
JP (1) JPS54119477A (xx)
AR (2) AR226154A1 (xx)
AT (1) AT375646B (xx)
AU (1) AU524287B2 (xx)
BE (1) BE873656A (xx)
CA (1) CA1124720A (xx)
DD (1) DD141309A5 (xx)
DE (1) DE2964681D1 (xx)
ES (1) ES476658A1 (xx)
FR (1) FR2416225A1 (xx)
GB (1) GB1593609A (xx)
HU (1) HU178203B (xx)
IL (1) IL56407A (xx)
IT (1) IT1109868B (xx)
LU (1) LU80856A1 (xx)
NZ (1) NZ189376A (xx)
PT (1) PT69147A (xx)
ZA (1) ZA7990B (xx)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4544401A (en) * 1979-10-22 1985-10-01 E. I. Du Pont De Nemours And Company Agricultural pyridinesulfonamides
US4435206A (en) 1978-12-04 1984-03-06 E. I. Du Pont De Nemours And Company Agricultural pyridinesulfonamides
US4879249A (en) * 1983-02-25 1989-11-07 Baldwin Thomas O Linker compounds, linker-compound-ligands and linker-compound-receptors
US4734275A (en) * 1983-08-19 1988-03-29 Research Corporation Anti-curare agents
DE3529529A1 (de) * 1985-08-17 1987-02-19 Boehringer Mannheim Gmbh Verfahren zur herstellung einer stabilen modifikation von torasemid
US4914203A (en) * 1987-07-24 1990-04-03 American Home Products Corporation 5 step process for preparing certain 2,4-diamino-5-pyrimidine-sulfonyl ureas
US4853389A (en) * 1987-07-24 1989-08-01 American Home Products Corporation Diuretic and antihypertensive substituted-5-pyrimidinesulfonylureas
FR2659080B1 (fr) * 1990-03-02 1994-07-08 Adir Nouveaux derives de la pyridylsulfonyluree et de la pyridylsulfonylthiouree, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
US5166162A (en) * 1990-03-02 1992-11-24 Adir Et Compagnie Pyridylsulfonylurea and pyridylsulfonylthiourea compounds
FR2685917A1 (fr) * 1992-01-06 1993-07-09 Adir Nouveau derive de la pyridylsulfonyluree des procedes de preparation et les compositions pharmaceutiques le contenant.
EP1741429A3 (en) * 2000-03-20 2007-01-17 Teva Pharmaceutical Industries Ltd. Processes for preparing torsemide
SK14802002A3 (sk) 2000-03-20 2003-05-02 Teva Pharmaceutical Industries Ltd. Nový spôsob prípravy medziproduktu torsemidu
DE10027887A1 (de) 2000-05-31 2001-12-13 Jenapharm Gmbh Verbindungen mit einer Sulfonamidgruppe und diese Verbindungen enthaltende pharmazeutische Zusammensetzungen
AR037097A1 (es) * 2001-10-05 2004-10-20 Novartis Ag Compuestos acilsulfonamidas, composiciones farmaceuticas y el uso de dichos compuestos para la preparacion de un medicamento
PE20040167A1 (es) * 2002-03-28 2004-05-26 Novartis Ag Amidas del acido sulfamico
IL149771A0 (en) * 2002-05-21 2002-11-10 Fintech Lab Ltd Process for preparation of torsemide
US7378527B2 (en) * 2004-03-16 2008-05-27 Daqing Che Process for the preparation of torsemide and related intermediates
US7534780B2 (en) 2004-05-21 2009-05-19 Bayer Schering Pharma Aktiengesellschaft Estradiol prodrugs
DE102005057421A1 (de) * 2005-11-30 2007-05-31 Bayer Schering Pharma Ag Heteroaromatische Sulfonamid-Prodrugs
AR061159A1 (es) 2007-06-01 2008-08-06 S A Cartocor Procedimiento de fabricacion de un pallet modular y producto resultante
EP3649112A1 (en) * 2017-07-07 2020-05-13 Inflazome Limited Sulfonylureas and sulfonylthioureas as nlrp3 inhibitors
CN114456104B (zh) * 2022-01-26 2023-08-25 南京正科医药股份有限公司 一种托拉塞米关键中间体的合成方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE758749A (fr) * 1969-11-12 1971-05-10 Ciba Geigy Procede de preparation de nouveaux acides pyridine-sulfoniques
GB1368948A (en) * 1970-11-11 1974-10-02 Manuf Prod Pharma Pyridine derivatives
GB1414793A (en) * 1972-07-28 1975-11-19 Manuf Prod Pharma Derivatives of phenylaminopyridine
US3956294A (en) * 1972-06-22 1976-05-11 Cassella Farbwerke Mainkur Aktiengesellschaft Substituted pyridine compounds
GB1477664A (en) * 1974-04-17 1977-06-22 Christiaens Sa A Pyridine derivatives

Also Published As

Publication number Publication date
CA1124720A (en) 1982-06-01
EP0003383B1 (fr) 1983-02-09
FR2416225A1 (fr) 1979-08-31
AU4331779A (en) 1979-08-09
ZA7990B (en) 1980-10-29
HU178203B (en) 1982-03-28
AR225922A1 (es) 1982-05-14
US4244950A (en) 1981-01-13
AT375646B (de) 1984-08-27
IT1109868B (it) 1985-12-23
PT69147A (en) 1979-02-01
BE873656A (fr) 1979-07-23
EP0003383A3 (en) 1979-09-05
LU80856A1 (fr) 1980-08-08
IT7919614A0 (it) 1979-01-25
DD141309A5 (de) 1980-04-23
ATA59479A (de) 1984-01-15
DE2964681D1 (de) 1983-03-17
EP0003383A2 (fr) 1979-08-08
NZ189376A (en) 1981-03-16
JPS54119477A (en) 1979-09-17
GB1593609A (en) 1981-07-22
ES476658A1 (es) 1979-07-16
FR2416225B1 (xx) 1981-11-06
IL56407A (en) 1983-05-15
IL56407A0 (en) 1979-03-12
AU524287B2 (en) 1982-09-09

Similar Documents

Publication Publication Date Title
AR226154A1 (es) Procedimiento para preparar derivados de 3-alquil(c1-c4)carbamoil-sulfonamido-4-amino-piridina y sus sales farmaceuticamente aceptables
AR240171A1 (es) Procedimiento para obtener derivados de 1-sulfo-2-oxo-azetidina y sus sales y esteres farmaceuticamente aceptable.
AR226285A1 (es) Procedimiento para la preparacion de 2-aril-aminotiazoles y sus sales de adicion de acidos farmaceuticamente aceptables
AR240807A1 (es) Procedimiento para obtener derivados de benzazepin-2-ona y sus sales
AR228575A1 (es) Procedimiento para obtener derivados de 7-hidroximetil o 7-carboxicamptotecina y sus sales
AR228444A1 (es) Procedimiento para preparar derivados de 5-bencil-tiazolidin-2,4-diona y sus sales
ES487464A0 (es) Procedimiento de preparacion de nuevos derivados aldehidos peptidil-argininos y de sus sales
AR230184A1 (es) Procedimiento para preparar derivados de 1-benzil-imidazol
AR229103A1 (es) Procedimiento para la preparacion de derivados de 3-aril-5-isotiazol y sus sales
MX4811E (es) Procedimiento para preparar derivados de prostaglandina
AR227556A1 (es) Procedimiento para preparar derivados de 2-fenil-amino-2-imidazolina y sus sales
AR230280A1 (es) Procedimiento para obtener derivados de carboestirilo y sus sales
AR228949A1 (es) Procedimiento para la preparacion de nuevos derivados de pirido(1,2-a)pirimidina y sus sales
AR225653A1 (es) Un procedimiento para la preparacion de derivados de n-(2-fenil-2-hidroxietil)-1-metil-3-fenil-propilamina y sus sales
AR212468A1 (es) Procedimiento para la preparacion de nuevos derivados de w-alquilamidas de acidos w amino-carboxilicos y sus sales
AR221081A1 (es) Procedimiento para preparar derivados de fenoximetil-piperidino-propoxi-indol
AR218454A1 (es) Procedimiento para preparar derivados de 7-beta-amino o 7-beta-(2-oximino-2-furil o 2-fenilacetamido)-3-(sulfoalquil o 3-sulfoaminalquilo o 3-sulfamilalquil-tetrazol-5-il)tiometil 3-cefem-4-carboxilicos y sus sales
DK94880A (da) D-2-hydroxy-4-methylmercaptosmoersyrederivater fremgangsmaade til fremstilling heraf samt anvendelse heraf
AR228586A1 (es) Procedimiento para preparar derivados de 2,3-dihidrobenzofuran-2-ona o croman-2-ona y sus sales farmaceuticamente aceptables
AR222311A1 (es) Procedimiento para preparar derivados de 1,2,3,3 alpha,8,8 alpha,hexahidropirrol-(2,3-b)indol y sus sales
MX6291E (es) Procedimiento para preparar derivados de n-bencilhalogenoacetamida
AR226446A1 (es) Procedimiento para preparar derivados de acidos fenilalcanoicos
AR228036A1 (es) Procedimiento para obtener derivados de 1-tio-alcanoilprolina y sus sales
AR223160A1 (es) Procedimiento para preparar derivados de 3-aminoalquiltiazolidindiona(2,4)y sus sales
AR216043A1 (es) Procedimiento para la preparacion de 1-derivados de benzoilamino-4-piperidina y sus sales fisiologicamente aceptables